Jeyanthi Ramanarayanan. “Advancements in Tyrosine Kinase Inhibitors Therapy: Role of Imatinib, the First Targeted Treatment for Chronic Myeloid Leukemia ”. Medicine and Medical Research: New Perspectives Vol. 3, Aug. 2024, pp. 30-44, doi:10.9734/bpi/mmrnp/v3/1238.